Last Updated On 1/14/2026 2:05:58 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.
| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| No Relationships to Disclose |
|
|
| Honoraria |
| Company: PER |
| Recipient: You |
| Company: Peerview |
| Recipient: You |
| Company: IDEOlogy Health |
| Recipient: You |
|
| Consulting or Advisory Role |
| Company: Janssen |
| Recipient: You |
| Company: GSK |
| Recipient: You |
| Company: Pfizer |
| Recipient: You |
| Company: BMS |
| Recipient: You |
| Company: Sanofi |
| Recipient: You |
| Company: Alexion Pharmaceuticals |
| Recipient: You |
| Company: Kite, a Gilead company |
| Recipient: You |
| Company: AstraZeneca |
| Recipient: You |
| Company: Regeneron |
| Recipient: You |
|
| Speakers' Bureau |
| Company: Leukemia, Lymphoma and Myeloma |
| Recipient: You |
| Company: Springer Nature |
| Recipient: You |
|
| Research Funding |
| Company: Sanofi |
| Recipient: You |
|
| Patents, Royalties, Other Intellectual Property |
| Please describe: Patent 11-1F4 mAb for use in AL Amyloidosis |
| Recipient: You |
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| Company: Regeneron |
| Recipient: You |
|
| Other Relationship |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Uncompensated Relationships |
| not answered |
|
|
| (OPTIONAL) Open Payments Link |
| not answered |
|
|